L’esperimento IMMUNE CELL ACTIVATION (ICA), finanziato dall’Agenzia Spaziale Europea (ESA) nell’ambito di un programma per la commercializzazione di prodotti innovativi, è stato lanciato verso la Stazione Spaziale Internazionale (ISS) in data 30 gennaio alle 12:07 p.m. EST (17:07 GMT) dallo spazioporto Kennedy Space Center di Cape Canaveral. L’esperimento è stato gestito dal servizio commerciale Bioreactor…
Kennedy Space Center (KSC), Cape Canaveral, Florida – 18th January 2024. The NanoProtection experiment (also known as PROMETEO-2), funded by the Italian Space Agency (ASI), has been successfully launched! PROMETEO-2 focuses on studying oxidative stress caused by the exposure of the human body to microgravity and cosmic radiation, conditions on Earth associated with pathologies such…
Lo scopo dell’esperimento OSTEOGENIC CELLS, condotto in collaborazione con un team scientifico dell’Università di Leuven (Belgio), è di investigare il comportamento in microgravità di specifiche linee cellulari (osteoblasti e cellule primarie periosteali) per comprendere gli effetti dell’ambiente spaziale sugli organismi viventi e per prevenire problemi specifici agli astronauti durante il lungo soggiorno in ambiente di…
ARED-Kinematics has been launched on-board SpX-28 from Cape Canaveral! June 5th, 2023 Cape Canaveral. ARED-Kinematics is a human physiology experiment supported by ASI and ESA, aimed to quantify the joint torque, muscle forces, and bone stresses that occur during exercise in microgravity, as well as to quantify adaptations in performance that may occur throughout a…
Kayser Italia, 10th May 2023: the team composed by Kayser Italia, the Department of Chemistry “Giacomo Ciamician” – University of Bologna and the School of Aerospace Engineering – Sapienza University of Rome, started to test the first prototype of the immune-analytical device APHRODITE. Results were satisfying and confirmed the design choices! Next steps will be…